Asia Pacific Tumor Ablation Market Size & Outlook
Asia Pacific tumor ablation market, 2018-2030 (US$M)
Related Markets
Asia Pacific tumor ablation market highlights
- The Asia Pacific tumor ablation market generated a revenue of USD 411.6 million in 2023.
- The market is expected to grow at a CAGR of 14.9% from 2024 to 2030.
- In terms of segment, radiofrequency ablation was the largest revenue generating technology in 2023.
- Irreversible Electroporation is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 411.6 million |
| Market revenue in 2030 | USD 1,085.2 million |
| Growth rate | 14.9% (CAGR from 2023 to 2030) |
| Largest segment | Radiofrequency ablation |
| Fastest growing segment | Irreversible Electroporation |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 24.6% of the global tumor ablation market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,085.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tumor Ablation Market Scope
Tumor Ablation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific tumor ablation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 35.81% in 2023. Horizon Databook has segmented the Asia Pacific tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is an emerging market for tumor ablation and is expected to grow at the fastest rate due to increasing disposable income, improving healthcare infrastructure, and rapidly growing economic conditions in the emerging markets of Japan, China, & India.
The introduction of advanced technology, such as multi-needle electrodes, with higher accuracy and cost-effectiveness as well as portability, is expected to serve the market as a driver due to customizability.
Thus, many collaborative partnerships and strategic alliances are underway between companies in this region, creating lucrative growth opportunities. Furthermore, most countries in this region, such as India & China, are developing economies and are exhibiting fast adoption of advanced technologies.
Reasons to subscribe to Asia Pacific tumor ablation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific tumor ablation market databook
-
Our clientele includes a mix of tumor ablation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific tumor ablation market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific tumor ablation market size, by country, 2018-2030 (US$M)
Asia Pacific Tumor Ablation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
